While surfing the web, I found these stories of interest:

• NCI Division of Cancer Epidemiology and Genetics (DCEG): Uncovering the causes of cancer, training future researchers.
  
• As reported in the Journal of Clinical Oncology, the American Society of Clinical Oncology (ASCO) has endorsed the recently published American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline on radiation therapy for oropharyngeal squamous cell carcinoma (OPSCC).
• Researchers at Icahn School of Medicine at Mount Sinai have developed the first mathematical model to predict how a cancer patient will benefit from select immunotherapies. To create this model, researchers used data from melanoma and lung cancer patients being treated with immune checkpoint inhibitors. Read more about this development in Nature.